SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-001007
Filing Date
2024-01-09
Accepted
2024-01-09 17:09:07
Documents
16
Period of Report
2024-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20240108_8k.htm   iXBRL 8-K 50710
2 EXHIBIT 4.1 ex_613098.htm EX-4.1 615751
3 EXHIBIT 10.1 ex_613097.htm EX-10.1 170114
4 EXHIBIT 10.2 ex_613355.htm EX-10.2 67819
  Complete submission text file 0001437749-24-001007.txt   1223380

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA opk-20240104.xsd EX-101.SCH 3400
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20240104_def.xml EX-101.DEF 11420
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20240104_lab.xml EX-101.LAB 15309
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20240104_pre.xml EX-101.PRE 11580
10 EXTRACTED XBRL INSTANCE DOCUMENT opk20240108_8k_htm.xml XML 2539
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 24524042
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)